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Abstract
Background: Africa is the world’s second-largest and 
most-populous continent. It is also the world’s poorest 
inhabited continent. Regarding chronic kidney disease 
(CKD), there are no reliable statistics in most African 
countries. However, there is a general impression that it 
is at least three to four times more frequent than in more 
developed countries
Methods: a survey on renal replacement therapy in Africa 
was conducted in the context of the African Association 
of Nephrology (AFRAN) Congress 2007. A questionnaire 
was sent to leading African nephrologists, and data were 
also collected from the main dialysis supply companies 
and by personal communication. Data have been obtained 
from 32 out of 54 countries, representing 89% of the total 
population. 
Results: There are no reliable statistics regarding CKD in 
most African countries. The total number of nephrologists 
in the continent is 1154 (1-4 pmp). The total number 
of patients on hemodialysis (HD) is just over 60000 
patients (<50 pmp in many countries). Peritoneal dialysis 
(PD) is only available in 12 African countries, and 
the total number of PD patients is around 2000. Renal 
transplantation is performed in 10 of the 53 countries, 
and only five countries have sustained programs that 
perform more than 50 cases per year. 
Conclusion: CKD is an under-recognized health 
challenge in Africa. Research should be encouraged to 
gauge the exact incidence and prevalence of CKD in 
African countries and define its regional risk factors. 
Efforts are needed to train physicians in this specialty, 
and strategies for judicious resources allocation should 
be implemented.
Key words: renal replacement therapy, chronic kidney 
disease, dialysis, transplantation, Africa
Background
Africa is the world’s second-largest and most-populous 
continent, after Asia. At about 30,221,532 km² 
(11,668,545 mi²) including adjacent islands, it covers 
6.0% of the Earth’s total surface area, and 20.4% of the 
total land area [1]. With more than 900,000,000 people 
(as of 2005) in 57 territories, it accounts for about 14% 
of the world’s human population [2]. There are 54 
countries including all the island groups. Due largely 
to the effects of the colonialism, the international trade 
regime, geopolitics, corrupt governments, despotism, 
and constant conflict, Africa is the world’s poorest 
inhabited continent. According to the United Nations’ 
Human Development Report in 2003, half of Africans 
lived in extreme poverty (on under $1 per day), and the 
bottom 25 ranked nations (151st to 175th) were all African 
nations [3]. The last 40 years have seen a rapid increase 
in population; hence, this population is relatively young. 
In some African states half or more of the population is 
under 25 years old. By most estimates, Africa contains 
well over a thousand languages.
Economic Indicators
The continent is divided into five major geographic sub-
regions according to the WHO statistics division, each 
region comprising several territories (figure 1). These 
regions are: Northern, Western, Middle, Eastern, and 
Southern African [4]. The population and gross domestic 
product (GDP) per capita vary significantly among these 
regions (table 1).
The population distribution as well as the per capita 
healthcare expenditure per year varies significantly 
among African countries in different territories (table 2). 
The Commission on Macroeconomics and Health (2001) 
estimates that $30-40 per person per year is the minimum 
required for essential health interventions in low-income 
countries [5]. The total per capita expenditure on health 
in Africa averaged 42(US$) in 2004, in comparison, the 
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e-mail in 2004 and 2006. Data were also requested from 
the main drug and dialysis supply companies, beside 
data available in literature and by oral communication. 
Completed questionnaires have been returned from 11 
countries. In total, data have been obtained from 32 out 
of 53 countries (60%) hosting 762 million people (89% 
of the total population). 
Results
Nephrologists and Renal Biopsy Services
The total number of nephrologists in the continent is 1154. 
Of these, 982 (80%) are based in North Africa (Egypt, 
Libya, Morocco, Tunisia and Algeria) and 50 (4%) in 
The Republic of South Africa. Their number per million 
population (pmp) is less than 1 pmp in 27 countries, 
up to 4 pmp in 6 countries and more than 4 pmp in 5 
North African countries. In Western Europe the average 
is 20 nephrologists pmp. Renal biopsy is available and 
routinely performed in only 8 out of 53 (15.4%) countries 
(table 3).
Hemodialysis (HD)
The total number of patients on HD in Africa is 61113. 
HD is often the only available RRT modality. HD is 
available in the public sector in 32 countries mainly in 
North and South Africa. It is also available in the private 
sector in 10 countries. The prevalence of patients under 
HD treatment is low, less than 50 patients pmp in many 
African countries, while it is over 500 patients pmp in 
European countries. North Africa - Egypt, Morocco, 
Libya, Algeria and Tunisia - comprise 54625 (89.4%) of 
HD patients whereas several countries have <100 patients 
pmp on regular HD, e.g. Burkina Faso, Ghana, Guinea, 
Mali, Niger and Togo (table 3). 
Peritoneal Dialysis (PD)
Among the 53 African countries, PD is only available in 
12 (23%), 5 in Northern Africa, 7 in the rest of Africa, 
Table 1: The population in millions and the gross domestic products for the major African geographic sub-regions [3,4]
Region Countries Population* GDP**
East 
African
19 territories, 17 countries: Burundi, Comoros, 
Djibouti, Eritrea, Ethiopia, Kenya, Madagas-
car, Malawi, Mauritius, Mayotte (France), 
Mozambique, Reunion (France), Rwanda, Sey-
chelles, Somalia, Uganda, United Republic 









Middle African 9 countries: Angola, Cameroon, Central 
African Republic, Chad, Congo, Demo-
cratic Republic of the Congo, Equatorial 
Guinea, Gabon, Sao Tome and Principe
Lowest: 
Sao Tome and Principe (0.2)
Highest: 
D.R. of Congo (49.8)
Lowest: 





7 countries: Algeria, Egypt, Libyan Arab Jama-











5 countries: Botswana, Lesotho, Namibia, 









Western Africa 17 territories, 16 countries: Benin, Burkina Faso, Cape 
Verde, Côte d’Ivoire, Gambia, Ghana, Guinea, Guinea-
Bissau, Liberia, Mali, Mauritania, Niger, Nigeria, 









* Population in millions (2001)
**Gross domestic product per Capita in $US (2001)
Tanzania respectively [8]. Diabetes mellitus is a major 
future challenge for Africa. It is currently affecting 
approximately 171 million individuals worldwide, a 
number that is projected to rise to 366 million in 2030 
[10]. The increase will be most notable in developing 
countries where > 75% of people with diabetes will 
reside, compared with 62% in 1995 [11].
Regarding chronic kidney disease (CKD), there are no 
reliable statistics in most African countries. However, 
there is a general impression that it is at least three 
to four times more frequent than in more developed 
countries [12]. A recent population survey in Khartoum 
has depicted CKD to affect 5.1% of all adults [13]. 
Etiology of end stage renal disease (ESRD) in the sub 
region differs from that seen in the developed world. 
As opposed to the situation in Europe and the United 
States, where diabetic nephropathy constitutes close to 
50% of patients on ESRD programs, the predominant 
causes of ESRD in Africa are essential hypertension and 
chronic glomerulonephritis (CGN) [14]. In 1994, CGN 
was recorded as the cause of ESRD in 1771 (52.1%) of 
patients and hypertension in 1549 (45.6%) of patients by 
the Statistics of the South African Dialysis and Transplant 
Registry (SADTR) [15].
Renal Replacement Therapy (RRT)
At the end of 2004, some 1 783 000 people worldwide 
were undergoing treatment for ESRD; 1371000 (i.e. 
77%) were on dialysis treatment and 412 000 (i.e. 23%) 
were living with a functioning renal transplant. Of those 
on dialysis; 89% (i.e. 1 222 000) were treated by HD 
and 11% (i.e. 149 000) were undergoing PD treatment 
[16]. The number of patients on dialysis is growing at 
an annual global average rate of 7%. The main factors 
contributing to the continued growth are the universal 
ageing of populations, multi-morbidity, higher life-
expectancy of treated ESRD patients and increasing 
access of a generally younger patient population to 
treatment in countries in which access had previously 
been limited [15]. In order to facilitate effective future 
planning by healthcare authorities, reliable information 
on ESRD patient numbers, development trends and 
treatment modalities are essential.
Methods
A survey was conducted on nephrology and RTT in 
the context of the African Association of Nephrology 
(AFRAN) Congress, February 2007, in order to collect 
current information. A questionnaire had been sent to 
the nephrology national societies’ presidents, African 
Association of Nephrology (AFRAN) board members 
and to leading nephrologists by regular mail, fax, and 
Figure 1: Map showing the major geographic African 
sub-regions [4]
per capita total health care expenditure in Europe was 
approximately 1537(US$) in the same year.[6]
Health Problems
Infectious diseases are the world’s leading cause of death, 
43% in the developing world compared to 1.2 % in the 
developed world [7]. The most significant illness in Africa 
has long been malaria. A new problem of vast magnitude 
is the rise of HIV/AIDS in Sub-Saharan Africa. AIDS, the 
spread of which correlates with poverty, has nevertheless 
hit hardest in some of the wealthiest African countries, 
including Botswana, Swaziland, and South Africa. AIDS 
has decimated or is likely to decimate the working-
age population of many states. Other major health 
problems in Africa are tuberculosis, gastroenteritis, other 
tropical infections, and hypertension. Based upon some 
estimates, 26.4% of the world’s adult population in the 
year 2000 had hypertension (26.6% in men and 26.1% in 
women), and 29.2% are predicted to have hypertension 
by the year 2025 (29.0% in men and 29.5% in women) 
[8]. Hypertension increases the risk of stroke, myocardial 
infarction, congestive heart failure, sudden cardiac death, 
peripheral vascular disease, and renal insufficiency [9]. 
Crude rates of hypertension from national surveys in 
some African countries were 26.3%, 23.9%, 15.4%, 
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Cost of Renal Replacement Therapy
Cost of RRT, in all countries, is out of the reach of 
individuals and represents a burden for the states. The cost 
of a single HD session is $ 65, 120, and 140 in Tunisia, 
Nigeria, and South Africa respectively. Regarding PD, 
the total annual cost per patient differs significantly in 
African countries. It varies between (in $US) 7,000 
(Egypt), 24,000 (Democratic Republic of Congo) and 
30,000 (South Africa). 
Renal transplantation cost differs by the year, being most 
expensive in the first year and dropping down on the 
subsequent years (table 4).
Discussion
CKD is a major health challenge which is under-
recognized in Africa. Risk factors are on the rise with 
diabetes, hypertension, and obesity slowly reaching 
pandemic scales in many African countries. A three 
pronged approach towards confronting the disease 
includes raising awareness, focusing on prevention and 
judiciously allocating resources for different types of 
RRT.
Research should be encouraged in different African 
countries to gauge the exact incidence and prevalence 
CKD and define its regional risk factors. Programs to 
prevent CKD and to treat it in the earliest stages must 
be designed and integrated into the existing health care 
infrastructure. 
The World Health Organization’s Innovative Care for 
Chronic Conditions Framework provides a model for 
redesigning health care systems in accordance with local 
resources. The framework emphasizes a well-defined 
care plan, self-care, scheduled follow-up appointments, 
monitoring of outcomes, adherence, and stepwise 
treatment protocols delivered mainly by primary care 
practitioners. However, increased referrals from such 
programs, even if limited to patients with advanced 
disease, may place excessive demands on existing 
nephrology services. As shown in this survey, there 
are only about 1154 nephrologists for a population of 
about 900 million (the United States has more than 5000 
nephrologists for a population of about 300 million). 
Efforts are therefore needed to train physicians in this 
specialty. For the time being, primary care practitioners 
will continue to be the frontline caregivers. These 
physicians should be required to participate in continuing 
medical education programs regarding the management 
of hypertension, diabetes, and CKD. 
Because RRT is quite expensive, strategies for judicious 
resources allocation should be implemented. Dialysis 
should be provided for short periods of time as a bridge 
to more definitive transplantation whether from live or 
cadaveric donors. PD is probably the more cost-effective 
dialysis modality; it is mostly self-administered, it secures 
the ability to work and study, and it excludes hospital 
charges and therefore is more realistic for patients living 
remotely form dialysis centers. Its cost should potentially 
drop further if fluids are locally produced. 
It is hoped to see a sustained improvement in the future 
with a greater emphasis on education, prevention, and 
development of renal services in the continent resulting 
in better patient outcomes.
Conclusion
CKD is an under-recognized health challenge in Africa. 
Research should be encouraged to gauge the exact 
incidence and prevalence of CKD in African countries 
and define its regional risk factors. 
Efforts are needed to train physicians in this specialty, 
and strategies for judicious resources allocation should 
be implemented.
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Table 4: Cost of renal transplantation in some African countries
Country First transplant year ($US) Subsequent years ($US)
Sudan 12,000 8,000
Tunisia 15,000 7,000
South Africa 20,000 15,000
most patients being in South Africa, and it is only being 
delivered in the public sector. Many of these units offer 
acute manual intermittent PD and only a few of them do 
regular PD. 
The total number of PD patients is around 1960. The 
prevalence is very low being less than 20 patients pmp in 
most countries (table 3), while it is more than 100 patients 
pmp in Western Europe. PD is often more expensive than 
HD in Africa because all components, including fluids 
must be imported.
South Africa has the largest PD patient population 
comprising 34.7% of its ESRD patients, with a total of 
1050 patients (53.6% of all African ESRD patients on 
PD) mostly on CAPD. Other countries patients’ numbers 
range from 13 to 490 on regular PD. PD has been recently 
introduced in the Sudan; the program has served about 
150 patients so far and its performance parameters are 
encouraging for other African countries [17].
Renal Transplantation
Renal transplantation is performed in 6 countries in 
North Africa (Algeria, Egypt, Libya, Morocco, Tunisia 
and Sudan) and 4 in sub-Saharan Africa (Cameroon, 
Kenya, Mauritius and South Africa), mainly in the public 
sector, with the donor pool being primarily live related 
donors (LRD). It is also available in private hospitals in 
Egypt, South Africa, and Sudan. Only 5 countries have a 
sustained program and perform more than 50 cases per 
year (table 3). Even in these countries many patients have 
to travel abroad for a kidney transplant when they can 
afford it. 
Table 2: The per capita gross national income and total health expenditure for some African countries [6]
Country Gross national income (GNI)* per capita 
(PPP international $) (2005)
Per capita total expenditure on health 
at average exchange rate (US$) (2004)











*The Gross National Income (GNI), formerly referred to as gross national product (GNP), measures the total domestic and foreign value added claimed 
by residents at a given period in time, usually a year, expressed in international dollars using purchasing power parity (PPP)  rates. GNI comprises GDP 
plus net receipts of primary income (compensation of employees and property income) from nonresident sources. GNI provides an aggregate measure 
of income. An international dollar is defined as the currency unit that has the same purchasing power over GNI as the US dollar in the United States.
Table 3: The distribution of nephrologists and renal replacement therapy in some African countries







Algeria 6 252 15 60
Burkina Faso 0.4 2 0 0
D.R. of  Congo 0.1 0 0.16 0
Egypt 6.5 421 0.3 500
Libya 5 370 1.4 50
Senegal 0.2 4.2 0.5 0
South Africa 1.1 46 24.4 240
Sudan 0.7 46 2.8 56
Tunisia 7 650 20 70
pmp: per million of population, HD: Hemodialysis, PD: Peritoneal Dialysis
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